Regulation of the initial segment of the murine epididymis by dihydrotestosterone and testicular exocrine secretions studied by expression of specific proteins and gene expression.
The murine caput epididymidis responded to deprivation of luminal fluid from the testis by regression of the initial segment but maintenance of the adjacent proximal and distal caput regions, as judged by immunohistochemical staining of the glutamate transporter EAAC1 and the lipocalin MEP17 and enzymatic activity of beta-galactosidase (beta-Gal). Additional removal of circulating androgens by bilateral castration similarly led to loss of the initial segment and of the proximal caput but the distal caput was transformed into an epithelium containing more apical than principal cells staining for EAAC1; this epithelium resembled the precursor epithelium usually only seen in prepubertal juveniles. Administration of dihydrotestosterone (DHT) to the castrates maintained the proximal and distal caput epithelia and induced a proximal epithelium, which resembled the initial segment in its prominent staining for Golgi, EAAC1 and beta-Gal activity, although it was short and exhibited no MEP17 expression. DHT was present in the c-ros knockout caput epididymidis lacking the initial segment and in the heterozygous organ but the DHT concentration was lower in the knockout corpus. The maintenance of the full complement of epithelia in the murine caput epididymidis in the adult thus requires a combination of luminal fluid from the testis, tissue DHT and the presence of the c-ros oncogene.
Avram
C
C
Institut für Reproduktionsmedizin, Universität Münster, Domagkstrasse 11, 48149, Germany.
Yeung
C-H
CH
Nieschlag
E
E
Cooper
T G
TG
D027322:Amino Acid Transport System X-AG / Q000378:metabolism; D000728:Androgens / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism; D002369:Castration / Q000009:adverse effects; D013196:Dihydrotestosterone / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology*; D004822:Epididymis / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D050580:Excitatory Amino Acid Transporter 3; D005786:Gene Expression Regulation / Q000187:drug effects; D050491:Glutamate Plasma Membrane Transport Proteins; D008026:Ligation / Q000009:adverse effects; D054834:Lipocalins; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009929:Organ Size / Q000187:drug effects; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics / Q000378:metabolism; D027981:Symporters / Q000378:metabolism; D013735:Testicular Hormones / Q000378:metabolism*; D001616:beta-Galactosidase / Q000235:genetics / Q000378:metabolism
D027322:Amino Acid Transport System X-AG; D000728:Androgens; D002352:Carrier Proteins; D050580:Excitatory Amino Acid Transporter 3; D050491:Glutamate Plasma Membrane Transport Proteins; C423382:Lcn8 protein, mouse; D054834:Lipocalins; D011518:Proto-Oncogene Proteins; C493399:Slc1a1 protein, mouse; D027981:Symporters; D013735:Testicular Hormones; D013196:Dihydrotestosterone; D020794:Receptor Protein-Tyrosine Kinases; C483813:Ros1 protein, mouse; D001616:beta-Galactosidase